Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | 7KD5B | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8369BA | IM / LA |
Dose was administered inadvertently 18 days after the 1st dose of Menquadfi and 2nd dose of the HPV was given. The pharmaceutical companies were contacted. There hasn't been any reported adverse events at the time this report is made
none
none
none
none
none